Hif-1a and Hif-2a synergize to suppress AML development but are dispensable for disease maintenance. (2015)

First Author: Vukovic M


No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1084/jem.20150452

PubMed Identifier: 26642852

Publication URI: http://europepmc.org/abstract/MED/26642852

Type: Journal Article/Review

Volume: 212

Parent Publication: The Journal of experimental medicine

Issue: 13

ISSN: 0022-1007